# R01 Duplication Analysis

## Mission

R01-001 - ROADMAP_REFACTORING_TO_200_MISSION_MODEL.

## Repeated Patterns Identified

### Source Corpus Programs

The SSRI corpus and SNRI corpus follow the same pattern:

```text
Source Discovery
Source Catalog
Source Corpus Intake
Metadata Normalization
Source Validation
Editorial Registration
Corpus Publication
Completion Gate
```

This pattern should become:

```text
Scientific Corpus Pipeline[DrugClass]
```

### Drug Class Population Programs

Class-specific scientific population follows the same structure:

```text
Drug Portfolio
Scientific Profile
Mechanism
Receptor/Neurotransmitter
PK
PD
Indications
Posology
Contraindications
Safety
Evidence
QA
Publication
```

This pattern should become:

```text
Drug Class Population Pipeline[DrugClass]
```

### Evidence And Publication

Evidence integration, QA and publication appear as repeated late-stage phases.

They should become:

```text
Evidence Integration Pipeline[DrugClass]
QA and Publication Pipeline[DrugClass]
```

## Duplicated Mission Families

- Source discovery.
- Source cataloging.
- Corpus intake.
- Metadata normalization.
- Source validation.
- Editorial registration.
- Corpus publication.
- Portfolio initialization.
- Drug profile initialization.
- Mechanism modeling.
- PK modeling.
- PD modeling.
- Safety modeling.
- Evidence binding.
- QA.
- Publication gates.

## Non-Compressible Areas

Some areas should not be compressed into generic automatic execution without explicit gates:

- Clinical Safety Contract.
- Evidence Traceability Policy.
- Runtime Eligibility Gate.
- Editorial Review Gate.
- Clinical release governance.
- ADRs for structural changes.

## Final Declaration

Most Track A class-by-class work is compressible into parameterized pipelines. Governance, safety and runtime gates must remain explicit.
